Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | Director | May 15, 2025 | May 16, 2025 |
| Huron Consulting Group Inc.HURN · Entity 4332 | Director | April 01, 2020 | April 03, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date May 15, 2025 · Filed May 16, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,575 |
Ending reported balance
After 2025-05-15 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2025-05-15 · Sale · Disposed 35 · Balance 5,680 F1: This transaction was executed in multiple trades at prices ranging from $136.07 to $136.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024. Row 2 · 2025-05-15 · Sale · Disposed 81 · Balance 5,599 F2: This transaction was executed in multiple trades at prices ranging from $137.19 to $138.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024. Row 3 · 2025-05-15 · Sale · Disposed 24 · Balance 5,575 F3: This transaction was executed in multiple trades at prices ranging from $139.02 to $139.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $136.07 to $136.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
F2: This transaction was executed in multiple trades at prices ranging from $137.19 to $138.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
F3: This transaction was executed in multiple trades at prices ranging from $139.02 to $139.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
Huron Consulting Group Inc.
Report date April 01, 2020 · Filed April 03, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,719 |
Reported balance
After 2020-04-01 transaction · row 1
1 source rowRow 1 · 2020-04-01 · Sale · Disposed 760 · Balance 17,719 F1: Automatic sale pursuant to a 10b5-1 plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Automatic sale pursuant to a 10b5-1 plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 05, 2017 Filed May 9, 2017 16:39 UTC | Huron Consulting Group Inc. HURN · Entity 4332 | GrantCommon Stock | 3,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-019016 · doc1.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,552 F1 · shares: Huron Consulting Group Inc. awarded restricted stock to reporting person. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 15:27 UTC | Huron Consulting Group Inc. HURN · Entity 4332 | SaleCommon Stock | 520 | $42.05 | $21,866.00 |
DisclosureSEC source: 0001140361-17-014763 · doc1.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,732 F1 · kind: Automatic sale pursuant to a 10b5-1 plan. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 21:15 UTC | Huron Consulting Group Inc. HURN · Entity 4332 | SaleCommon Stock | 520 | $48.60 | $25,272.00 |
DisclosureSEC source: 0001140361-17-000697 · doc1.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,252 F1 · kind: Automatic sale pursuant to a 10b5-1 plan. Read SEC document |
| December 06, 2016 Filed Dec 7, 2016 20:37 UTC | Huron Consulting Group Inc. HURN · Entity 4332 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-089010 · doc1.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,772 F1 · kind: Mr. Massaro gifted 1,000 shares to The Fidelity Charitable Gift Fund, a donor advised fund. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 17:07 UTC | Huron Consulting Group Inc. HURN · Entity 4332 | SaleCommon Stock | 518 | $59.39 | $30,764.02 |
DisclosureSEC source: 0001140361-16-081930 · doc1.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,772 F1 · kind: Automatic sale pursuant to a 10b5-1 plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.18 to $59.68. The undersigned undertakes to provide Huron Consulting Group Inc. ("Huron"), any security holder of Huron or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| July 15, 2016 Filed Jan 23, 2017 14:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-002203 · form5.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,395 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.